摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(5S)-1'-[(3,5-dimethylphenyl)methyl]-2-(2-hydroxyethyl)-6,8-dimethoxy-5-methylspiro[5,10-dihydroimidazo[1,5-b][2]benzazepine-3,4'-piperidine]-1-one | 1155773-17-3

中文名称
——
中文别名
——
英文名称
(5S)-1'-[(3,5-dimethylphenyl)methyl]-2-(2-hydroxyethyl)-6,8-dimethoxy-5-methylspiro[5,10-dihydroimidazo[1,5-b][2]benzazepine-3,4'-piperidine]-1-one
英文别名
——
(5S)-1'-[(3,5-dimethylphenyl)methyl]-2-(2-hydroxyethyl)-6,8-dimethoxy-5-methylspiro[5,10-dihydroimidazo[1,5-b][2]benzazepine-3,4'-piperidine]-1-one化学式
CAS
1155773-17-3
化学式
C30H39N3O4
mdl
——
分子量
505.657
InChiKey
FFHKAWDVPGUEJW-QFIPXVFZSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.4
  • 重原子数:
    37
  • 可旋转键数:
    6
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    65.5
  • 氢给体数:
    1
  • 氢受体数:
    5

反应信息

  • 作为产物:
    描述:
    1'-[(3,5-Dimethylphenyl)methyl]-2-(2-hydroxyethyl)-6,8-dimethoxy-5-methylspiro[5,10-dihydroimidazo[1,5-b][2]benzazepine-3,4'-piperidine]-1-one 以 正庚烷异丙醇 为溶剂, 以42%的产率得到(5S)-1'-[(3,5-dimethylphenyl)methyl]-2-(2-hydroxyethyl)-6,8-dimethoxy-5-methylspiro[5,10-dihydroimidazo[1,5-b][2]benzazepine-3,4'-piperidine]-1-one
    参考文献:
    名称:
    [EN] METHOD OF MAKING IMIDAZOAZEPINONE COMPOUNDS
    [FR] PROCÉDÉ DE FABRICATION DE COMPOSÉS IMIDAZOAZÉPINONES
    摘要:
    通过以下步骤制备化合物I的方法:(a)提供化合物II或III:其中环A为C3-14芳基或C3-14杂芳基,如苯基或呋喃基;然后(b)将化合物II或III与酸结合以产生化合物I。
    公开号:
    WO2009070305A1
点击查看最新优质反应信息

文献信息

  • [EN] METHOD OF MAKING IMIDAZOAZEPINONE COMPOUNDS<br/>[FR] PROCÉDÉ DE FABRICATION DE COMPOSÉS IMIDAZOAZÉPINONES
    申请人:EISAI E & D MAN CO LTD
    公开号:WO2009070305A1
    公开(公告)日:2009-06-04
    A method of making a compound of Formula I: is carried out by (a) providing a compound of Formula (II) or (III): wherein ring A is C3-14 aryl or C3-14 heteroaryl such as phenyl or furanyl, and then (b) combining the compound of Formula (II) or (III) with an acid to produce a compound of Formula I.
    通过以下步骤制备化合物I的方法:(a)提供化合物II或III:其中环A为C3-14芳基或C3-14杂芳基,如苯基或呋喃基;然后(b)将化合物II或III与酸结合以产生化合物I。
  • ENANTIOMERICALLY ENRICHED IMIDAZOAZEPINONE COMPOUNDS
    申请人:Spyvee Mark
    公开号:US20090197867A1
    公开(公告)日:2009-08-06
    The present invention provides an enantiomerically pure compound of Formula I: along with pharmaceutical formulations containing the same and methods of use thereof.
  • METHODS OF USE
    申请人:Chen Qian
    公开号:US20100305098A1
    公开(公告)日:2010-12-02
    A method of treating a disorder such as rheumatoid arthritis or multiple sclerosis in a subject is carried out by administering to the subject a composition comprising a modulator compound of Th1 differentiation or Th17 expansion.
  • METHOD OF MAKING IMIDAZOAZEPINONE COMPOUNDS
    申请人:Spyvee Mark
    公开号:US20110065916A1
    公开(公告)日:2011-03-17
    A method of making a compound of Formula I: is carried out by (a) providing a compound of Formula (II) or (III): wherein ring A is C3-14 aryl or C3-14 heteroaryl such as phenyl or furanyl, and then (b) combining the compound of Formula (II) or (III) with an acid to produce a compound of Formula I.
  • [EN] METHODS OF USE<br/>[FR] PROCÉDÉS D'UTILISATION
    申请人:EISAI E & D MAN CO LTD
    公开号:WO2009064431A1
    公开(公告)日:2009-05-22
    A method of treating a disorder such as rheumatoid arthritis or multiple sclerosis in a subject is carried out by administering to the subject a composition comprising a modulator compound of Th1 differentiation or Th17 expansion.
查看更多